• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Frankfurt	89,660	27.06.24 19:47:18	-1,220	-1,34%	89,380	89,550	90,210	90,880
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	993,000	27.06.24 08:12:54	-13,500	-1,34%	978,400	984,600	993,000	1.006,500